Evelina Kazlauske

Evelina Kazlauske

Auto-generated profile, based on publicly available information

Evelina Kazlauske

Biomedical Physics Laboratory of National Cancer Institute, Vilnius, Lithuania

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
EVEvelina Voronovic
Evelina Voronovic
ASArtiom Skripka
Artiom Skripka
GBGreta Butkiene
Greta Butkiene
MGMarija Ger
Marija Ger
DKDalius Kuciauskas
Dalius Kuciauskas
VKVitalijus Karabanovas
Vitalijus Karabanovas
Fluorophores with multifunctional properties known as rare-earth-doped nanoparticles (RENPs) are promising candidates for bioimaging, therapy, and drug delivery. When applied in vivo, these nanoparticles (NPs) have to retain long blood-circulation time, bypass elimination by phagocytic cells, and successfully arrive at the target area. Usually, NPs in a biological medium are exposed to proteins, which form the so-called “protein corona” (PC) around the NPs and influence their targeted delivery and accumulation in cells and tissues. Different surface coatings change the PC size and composition, subsequently deciding the fate of the NPs. Thus, detailed studies on the PC are of utmost importance to determine the most suitable NP surface modification for biomedical use. When it comes to RENPs, these studies are particularly scarce. Here, we investigate the PC composition and its impact on the cellular uptake of citrate-, SiO2-, and phospholipid micelle-coated RENPs (LiYF4:Yb3+,Tm3+). We observed that the PC of citrate- and phospholipid-coated RENPs is relatively stable and similar in the adsorbed protein composition, while the PC of SiO2-coated RENPs is larger and highly dynamic. Moreover, biocompatibility, accumulation, and cytotoxicity of various RENPs in cancer cells have been evaluated. On the basis of the cellular imaging, supported by the inhibition studies, it was revealed that RENPs are internalized by endocytosis and that specific endocytic routes are PC composition dependent. Overall, these results are essential to fill the gaps in the fundamental understanding of the nano-biointeractions of RENPs, pertinent for their envisioned application in biomedicine.

10 September 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
GBGreta Butkiene
Greta Butkiene
ADAleja Marija Daugelaite
Aleja Marija Daugelaite
VPVilius Poderys
Vilius Poderys
RMRiccardo Marin
Riccardo Marin
SSSimona Steponkiene
Simona Steponkiene
VKVitalijus Karabanovas
Vitalijus Karabanovas
Nanoparticles engineered to combat cancer and other life-threatening diseases may significantly improve patient outcomes. However, inefficient nanoparticle delivery to tumors limits their use and necessitates the development of complex delivery approaches. Here, we examine this issue by harnessing the tumor-homing abilities of human mesenchymal stem cells (MSCs) to deliver a decoupled theranostic complex of rare earth-doped nanoparticles (dNPs) and photosensitizer chlorin e6 (Ce6) to tumors. We show that both bone-marrow- and skin-derived MSCs can transport the dNP-Ce6 complex inside tumor spheroids, which is challenging to accomplish by passive delivery alone. MSCs deliver the dNP-Ce6 complex across the tumor spheroid, facilitating more effective photodynamic damage and tumor destruction than passively accumulated dNP-Ce6. The dNP-Ce6 complex also provides the built-in ability to monitor the MSC migration without causing undesired phototoxicity, which is essential for maximal and side-effect-free delivery of nanoparticles. Our results demonstrate how MSCs can be used as delivery vehicles for the transportation of the dNP-Ce6 complex, addressing the limitations of passive nanoparticle delivery and providing light-based theranostics.

10 December 2021 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
VKVaidas Klimkevicius
Vaidas Klimkevicius
EVEvelina Voronovic
Evelina Voronovic
GBGreta Butkiene
Greta Butkiene
ASArtiom Skripka
Artiom Skripka
FVFiorenzo Vetrone
Fiorenzo Vetrone
VKVitalijus Karabanovas
Vitalijus Karabanovas
Upconverting nanoparticles (UCNPs) possess great potential for biomedical application. UCNPs absorb and convert near-infrared (NIR) radiation in the biological imaging window to visible (Vis) and even ultraviolet (UV) radiation. NIR excitation offers reduced scattering and diminished autofluorescence in biological samples, whereas the emitted UV-Vis and NIR photons can be used for cancer treatment and imaging, respectively. However, UCNPs are usually synthesized in organic solvents and are not readily suitable for biomedical application due to the hydrophobic nature of their surface. Herein, we have removed the hydrophobic ligands from the synthesized UCNPs and coated the bare UCNPs with two custom-made hydrophilic polyelectrolytes (synthesized via the reversible addition–fragmentation chain transfer (RAFT) polymerization method). Polymers containing different amounts of PEGylated and carboxylic groups were studied. Coating with both polymers increased the upconversion (UC) emission intensity and photoluminescence lifetime values of the UCNPs, which directly translates to more efficient cancer cell labeling nanoprobes. The polymer composition plays a crucial role in the modification of UCNPs, not only with respect to their colloidal stability, but also with respect to the cellular uptake. Colloidally unstable bare UCNPs aggregate in cell culture media and precipitate, rendering themselves unsuitable for any biomedical use. However, stabilization with polymers prevents UCNPs from aggregation, increases their uptake in cells, and improves the quality of cellular labeling. This investigation sheds light on the appropriate coating for UCNPs and provides relevant insights for the rational development of imaging and therapeutic tools.

1 August 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
ABAusteja Butkute
Austeja Butkute
EKEvelina Kazlauske
Evelina Kazlauske
AMAgata Mlynska
Agata Mlynska
EPEmile Peciukaityte
Emile Peciukaityte
VKVitalijus Karabanovas
Vitalijus Karabanovas
SSSimona Steponkiene
Simona Steponkiene
Background: Photodynamic therapy (PDT) is a promising tool that utilizes photosensitizers (PS) for two functions: cancer imaging by fluorescence (diagnostics), and treatment by the generation of reactive oxygen species (therapy). Despite its theranostic approach, the efficacy of PDT is often hampered by limited penetration of light into tissues, tumor heterogeneity, and the immunosuppressive tumor microenvironment (TME). Moreover, diagnostics and treatment are activated simultaneously, without the possibility of switching between two processes. Methods: We used photosensitizer chlorin e6 (Ce6) and luminescent quantum dots (QDs) to create a theranostic nanocomplex. Two different light sources were used (980 nm or 650 nm light) to activate either the photoluminescence of quantum dots (QDs) or the generation of singlet oxygen by Ce6. Four distinct CRC cell lines were utilized to represent tumor heterogeneity. The therapeutic efficacy of nanocomplex was assessed in CRC and tumor-associated macrophages (TAMs), a key component of the immunosuppressive TME. Immunomodulatory effects were explored by exposing resident and recruited TAM models to a conditioned medium from PDT-treated CRC cells, followed by gene expression analysis. Results: Spectral characterization of the QDs-Ce6 nanocomplex demonstrated selective switching between diagnostic and therapeutic modes. Two-photon absorption was activated in QDs by 980 nm laser, thus broadening its excitation capabilities into the infrared region. The nanocomplex accumulated efficiently and uniformly across all CRC cell lines, regardless of their aggressiveness or drug sensitivity. The effect of nanocomplex-assisted PDT was the same among CRC cell lines, contrasting with the variable sensitivity to 5-fluorouracil. Additionally, the PDT caused M2 macrophages to lose their pro-tumor characteristics while potentiating their ability to present antigens. Additionally, M0 macrophages displayed a reduction in immunosuppressive signaling. Conclusion: The QDs-Ce6 nanocomplex exhibits robust photodynamic cytotoxicity and immunomodulatory potential. These findings highlight the potential of nanocomplex for targeting the aggressive type of tumor cells and the TAM.